Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

America's Well-To-Do Have Less Heart Disease Risk

Well-to-do and better-educated Americans have far lower rates of heart disease than the rest of the population, a new study says. The top 20 of high-income, col

USDA Disbands Two Key Food Safety Committees

Two key federal advisory committees on food safety have been shut down, raising concerns among food safety advocates. The move was part of a Trump administratio

Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate

Vaxart, Inc. (Nasdaq VXRT) today announced the initiation of a Phase 1, open label, dose ranging clinical trial evaluating its second-generation oral norovirus

Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial

Arvinas, Inc. (Nasdaq ARVN) and Pfizer Inc. (NYSE PFE) today announced positive topline results from the Phase 3 VERITAC-2 clinical trial (NCT05654623) evaluati

2017 to 2023 Saw Decline in Exclusive Cigarette Smoking, Rise in Vaping

Decreases in exclusive cigarette smoking and increases in exclusive electronic cigarette use were seen among U.S. adults from 2017 to 2023, according to researc

Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients

Biogen Inc. (Nasdaq BIIB) announced the initiation of dosing in the global clinical study, TRANSCEND. The Phase 3 study will evaluate the efficacy and safety of

First Clinical Data for Gilead’s Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet

Gilead Sciences, Inc. (Nasdaq GILD) today presented the first data from its ongoing Phase 1 study investigating two novel, once-yearly formulations of lenacapav

Free COVID-19 Test Program Stops Taking Orders

The U.S. government program that provides free at-home COVID tests is no longer accepting orders. The Administration for Strategic Preparedness and Response (AS

HHS Employees Offered as Much as $25K To Leave Jobs

In a sweeping effort to downsize the federal workforce, the U.S. Department of Health and Human Services (HHS) has offered buyouts of up to 25,000 to many of it

AAOS: Stopping GLP-1 RAs 14 Days Before Surgery Can Minimize Complications

Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize risks for complications, according t

Popular Keywords